Search Within

Martee L Hensley

  1. "Biostatistics Service"
Formats
  1. Journal Article (54)
  2. Meeting Abstract (27)
Groups
  1. Biostatistics Service (81)
  2. Department of Medicine (81)
  3. Epidemiology and Biostatistics (81)
  4. GDMT, Medicine (81)
  5. Gynecologic Medicine Service (81)
  6. Gynecology Disease Management Team (81)

More Groups

People
  1. Alexia Iasonos (52)
  2. Carol Aghajanian (46)
  3. Paul Sabbatini (38)
  4. David Spriggs (29)
  5. Qin Zhou (29)
  6. Jason Konner (22)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (5)
  5. 2021 (1)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Gynecologic Oncology (21)
  3. International Journal of Gynecological Cancer (10)
  4. Cancer (5)
  5. Clinical Cancer Research (4)
  6. Cancer Immunology, Immunotherapy (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (29)
  2. Elsevier Inc. (23)
  3. Lippincott Williams & Wilkins (10)
  4. American Association for Cancer Research (5)
  5. Wiley Blackwell (5)
  6. Springer (2)

More Publishers

Results (81)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome
    Journal Article

    Pedra Nobre, S.; Hensley, M. L.; So, M.; Zhou, Q. C.; Iasonos, A.; Leitao, M. M. Jr; Ducie, J.; Chiang, S.; Mueller, J. J.; Abu-Rustum, N. R.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes
    Journal Article

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Qin, L. X.; Chi, P.; Dickson, M.; Gounder, M.; Kelly, C.; Keohan, M. L.; Nacev, B.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer
    Meeting Abstract

    Rubinstein, M. M.; Hyman, D.; Caird, I.; O'Cearbhaill, R.; Grisham, R.; Tew, W.; Hensley, M.; Sabbatini, P.; Aghajanian, C.; Iasonos, A.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
    Journal Article

    Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • DNA damage response pathway alterations and clinical outcome in leiomyosarcoma
    Meeting Abstract

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Qin, L. X.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib and dacarbazine for leiomyosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumors
    Journal Article

    D'Adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C. M.; Ezeoke, M. O.; Ahn, L.; Qin, L. X.; Antonescu, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer
    Journal Article

    LaVigne, K.; Hyman, D. M.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; Aghajanian, C.; Makker, V.; Hensley, M. L.; Konner, J.; Grisham, R. N.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2, single arm study of iniparib in patients with BRCA1 or BRCA2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Journal Article

    Bell-McGuinn, K. M.; Konner, J. A.; Tew, W. P.; Hensley, M. L.; Iasonos, A.; Charpentier, E.; Mironov, S.; Sabbatini, P.; Aghajanian, C.
    International Journal of Gynecological Cancer (2016)

    Fulltext@MSK | Save